Authum Invests ₹36 Cr in Rivaara Labs

  Published 7 months ago

Authum Investment plans Rs 36 crore CCPS infusion and Rs 56.83 lakh purchase for Rivaara Labs' growth.

  • Rivaara Labs operates pathology, imaging, PCR testing, and genomic sequencing diagnostic service centres across India
  • Investment includes Rs 36 crore for 3.6 crore CCPS, plus Rs 56.83 lakh for acquiring existing securities of equity and convertible
  • Authum Investment focuses on loan provision, share trading, and strategic investments for a sustainable growth future

You might like these

Hyundai India: May Sales & Outlook

Infosys & Zoetis: Boosting Animal Health with AI & Automation

Reliance Invests in Facegym for Beauty Expansion

Tesla Sales Dip as European EV Market Booms

Bharat Dynamics Dips on Valuation Call

India Waives Customs on Defence Imports

Hindustan Zinc Launches Tailings Plant

News that matters the most ⚡